Arkuda Therapeutics
- Website
- arkudatx.com
- Total Funding
- $108.0M
- Last Round
- $44.0M Series AFeb 2022
- Rounds
- 2
About
Progranulin and lysosomal biology for neurodegeneration
Summary
It has raised $108.0M in total across 2 rounds, most recently a $44.0M Series A round in Feb 2022. Investors include Atlas Venture, Pfizer Ventures and Tekla Capital Management.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
$64.0M
Feb 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
